Venoarterial modified ultrafiltration versus conventional arteriovenous modified ultrafiltration during cardiopulmonary bypass surgery [PDF]
BACKGROUND AND OBJECTIVES: Different types of modified ultrafiltration (MUF) systems evaluated showed that none of the MUF techniques adhered to the normal venous to arterial blood flow dynamics.
Rakesh Mohanlall +2 more
doaj +4 more sources
Comparison of conventional and modified ultrafiltration on perioperative clinical outcome in neonates undergoing arterial switch operation [PDF]
Objective: The aim of this prospective, randomized study is to compare the effects of conventional ultrafiltration (CUF) versus combined CUF and modified ultrafiltration (MUF) in neonates undergoing an arterial switch operation (ASO) for transposition of
Jyoti Masaniya +4 more
doaj +2 more sources
A randomized study on the impact of optimized modified ultrafiltration on the physiological parameters of infants and children undergoing a cardiopulmonary bypass [PDF]
Background The aim of this study is to assess the impact of optimized modified ultrafiltration (OMUF) on the physiological parameters of infants and children undergoing cardiopulmonary bypass (CPB). Methods In this randomized clinical trial, 30 pediatric
Jianhong Niu +6 more
doaj +2 more sources
Effects of modified ultrafiltration and conventional ultrafiltration combination on perioperative clinical outcomes in pediatric cardiac surgery: A meta-analysis. [PDF]
Abstract Background: This meta-analysis was performed to review the effects of the addition of modified ultrafiltration (MUF) and conventional ultrafiltration (CUF) to CUF alone on postoperative hemoglobin, surgical and ultrafiltration data, and postoperative clinical outcomes in pediatric patients undergoing cardiac ...
Hu J +5 more
europepmc +3 more sources
Role of urinary PO2 analysis during conventional versus conventional and modified ultrafiltration techniques in adult cardiac surgery [PDF]
Background: Medullary hypoxia is the initial critical event for kidney injury during cardiopulmonary bypass, and therefore urinary PO2 with its potential of detecting medullary oxygenation for its management.
Vijitha Burra +6 more
doaj +2 more sources
The effect of modified ultrafiltration on angiopoietins in pediatric cardiothoracic operations. [PDF]
Cardiopulmonary bypass subjects patients' blood to hemodilution and nonphysiologic conditions, resulting in a systemic inflammatory response. Modified ultrafiltration (MUF) counteracts hemodilution and has also been postulated to improve outcomes by proinflammatory cytokine removal. The objective of this study was to investigate whether the benefits of
Lang SM +6 more
europepmc +4 more sources
Improved Removal of Neonicotinoid Insecticides from Real Water Matrices by Modified UF and NF Membranes [PDF]
The removal of five neonicotinoid insecticides, acetamiprid, chlothianidin, imidacloprid, thiacloprid, and thiamethoxam, was explored using various commercial ultrafiltration (MW, PT, and GK) and nanofiltration (HL) membranes provided by GE Osmonics ...
Francisco J. Real +3 more
doaj +2 more sources
Optimization of 2D Ag-MBene-Modified Polyethersulfone Ultrafiltration Membranes for Enhanced Water Treatment Performance [PDF]
Modified PES ultrafiltration membranes containing Ag-MBene nanoparticles were developed via the non-solvent-induced phase separation (NIPS) technique and evaluated for tertiary-treated sewage (TSE) filtration applications. This study aims to establish an
Asam Amin Almulla, Fikri T. Dweiri
doaj +2 more sources
An exploratory assessment of icodextrin for ultrafiltration failure subtypes in peritoneal dialysis [PDF]
Although icodextrin was initially developed for rapid transporters (type 1 UFF), emerging evidence suggests its effects might be independent of peritoneal membrane transport characteristics. This study aimed to evaluate the suitability of 7.5% icodextrin
Chuishun Yang +3 more
doaj +2 more sources
SGLT2 inhibitors as a strategy for volume management in peritoneal dialysis: a case series [PDF]
Sodium–glucose cotransporter 2 inhibitors (SGLT2i) have demonstrated cardiovascular and renal benefits in chronic kidney disease, yet their role in peritoneal dialysis (PD) remains largely unexplored, and clinical experience is limited.
R. Haridian Sosa Barrios +13 more
doaj +2 more sources

